Generation of High-Quality Antibodies/Peptides with High Diversity

Platform where wet lab and AI are integrated (Patented)

Over 1 billion proprietary biopharmaceutical data, obtained from our lab.
Our proprietary method and AI technology enable us to identify hidden valuable antibodies/peptides by predicting fundamental properties of biopharmaceuticals, e.g. affinity, specificity, phage growth bias in E. coli, immunogenicity, etc.

Models of Collaboration

Please feel free to contact us

 

 

Our core technologies

We perform directed evolution experiments such as phage display and mRNA/cDNA display, in our wet lab and collect big data via NGS.

Machine learning model is utilized to predict features of biopharmaceuticals, e.g. deep neural networks, transformers, generative models, etc.

Original machines for laboratory automation allow us to generate data quickly for developing machine learning models.

Team

ogawasan_maru

Ryu Ogawa, Ph.D.
CEO/Co-founder

tamakisan_maru

Satoshi Tamaki, Ph.D.
CSO

negishisan_maru

Natsumi Negishi
CFO

miurasan_maru

Kengo Miura
External director

tsutsumi-san

Tatsuo Tsutsumi
External director

abesan_maru

Hiroshi Abe
Statutory auditor

takahashisan_maru

Koichi Takahashi, Ph.D.
Adviser

Contact Us

Email: contact@molcure.io